Ms Regina Maria Morales, LCSW-C | |
17117 Trundle Rd, Dickerson, MD 20842-9348 | |
(240) 234-9196 | |
Not Available |
Full Name | Ms Regina Maria Morales |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 17117 Trundle Rd, Dickerson, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225107329 | NPI | - | NPPES |
265431800 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 10521 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Regina Maria Morales, LCSW-C 17117 Trundle Rd, Dickerson, MD 20842-9348 Ph: (240) 234-9196 | Ms Regina Maria Morales, LCSW-C 17117 Trundle Rd, Dickerson, MD 20842-9348 Ph: (240) 234-9196 |
News Archive
UTEK Corporation, a leading IP licensing and innovation services company, is pleased to announce a new pricing model for its Pharmalicensing online service; the pricing will be effective starting January 13th.
The long-running battle to defund or derail the health law came to a head Monday when Congress failed to approve a short-term spending measure to continue funding the government. For an entrenched group of House Republicans, Obamacare is the sticking point. But a new round of polls finds public opinion doesn't support their strategy.
In a recent bioRxiv* preprint paper, Professor Miles W. Carroll et al. study an agonist for reducing the SARS-CoV-2's viral load. They show that prophylactic intra-nasal administration of TLR2/6 (toll-like receptor) agonist, INNA-051, reduces viral RNA in the nose and throat, in a ferret model.
The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).
Changing the way consumers pay for prescription drugs so that the system more closely resembles paying for cell phones or computer software could increase drug use without altering patients' out-of-pocket spending, health plan costs or drug company profits, according to a new RAND Corporation study.
› Verified 9 days ago